Stocklytics Platform
Asset logo for symbol CLBT
Cellebrite DI Ltd.
CLBT65
$13.97arrow_drop_up2.00%$0.27
Asset logo for symbol CLBT
CLBT65

$13.97

arrow_drop_up2.00%

Performance History

Chart placeholder
Key Stats
Open$13.20
Prev. Close$13.15
EPS-0.58
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range13.08
13.55
52 Week Range6.36
13.55
Ratios
EPS-0.58

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

Correlated Companies

Asset logo for symbol AAPL
Apple
AAPL59
Price$217.96
Perf. (24h)
arrow_drop_up0.21%$0.47
Market Cap$3.34T
Asset logo for symbol MSFT
Microsoft
MSFT78
Price$425.26
Perf. (24h)
arrow_drop_up1.64%$6.87
Market Cap$3.13T
Asset logo for symbol NVDA
NVIDIA
NVDA90
Price$113.06
Perf. (24h)
arrow_drop_up0.69%$0.78
Market Cap$2.82T
Asset logo for symbol AVGO
Broadcom
AVGO72
Price$151.63
Perf. (24h)
arrow_drop_up1.58%$2.37
Market Cap$705.81B

About Cellebrite DI Ltd. (CLBT)

Cellebrite DI Ltd., also known as CLBT, is a company that specializes in digital intelligence solutions. They provide various products and services for law enforcement and intelligence agencies, as well as corporations and private individuals. With a strong focus on cybersecurity and data analysis, Cellebrite DI Ltd. is a leader in the field of digital forensics. They offer cutting-edge tools and technologies to help investigators uncover valuable evidence from digital devices. Their software solutions enable efficient and effective data extraction, decoding, and analysis, making it easier to solve crimes and gather intelligence. Additionally, Cellebrite DI Ltd. provides training and support to ensure that their customers can maximize the capabilities of their products.
As of [current date], the stock price of Cellebrite DI Ltd. (CLBT) is [stock price]. Over the years, the stock has shown a fluctuating trend, influenced by various market factors. Investors and analysts closely follow CLBT's stock price history to make informed decisions. In terms of market capitalization, Cellebrite DI Ltd. has a value of [market cap], reflecting its significance in the industry. When analyzing the stock, it's essential to consider factors such as the company's financials, industry trends, and potential growth opportunities.
Websitecall_made
Sector
Technology
Industry
Software—Infrastructure
CEO
Mr. Yossi Carmil
Headquarters
Petah Tikva
Employees
1005
Exchange
NASDAQ
add Cellebrite DI Ltd. to watchlist

Keep an eye on Cellebrite DI Ltd.

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Cellebrite DI Ltd.'s (CLBT) price per share?
The current price per share for Cellebrite DI Ltd. (CLBT) is $13.98. The stock has seen a price change of $0.28 recently, indicating a 2.01% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Cellebrite DI Ltd. (CLBT)?
For Cellebrite DI Ltd. (CLBT), the 52-week high is $14.05, which is 0.54% from the current price. The 52-week low is $6.36, the current price is 119.56% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Cellebrite DI Ltd. (CLBT) a growth stock?
Cellebrite DI Ltd. (CLBT) has shown an average price growth of 0.41% over the past three years. It has received a score of 79 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Cellebrite DI Ltd. as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Cellebrite DI Ltd. (CLBT) stock price performance year to date (YTD)?
As of the latest data, Cellebrite DI Ltd. (CLBT) has a year-to-date price change of 65.78%. Over the past month, the stock has experienced a price change of 18.53%. Over the last three months, the change has been 30.49%. Over the past six months, the figure is 55.62%.
help
Is Cellebrite DI Ltd. (CLBT) a profitable company?
Cellebrite DI Ltd. (CLBT) has a net income of -$81.1M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 83.63% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 10.2% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $325.11M, with a revenue growth rate of 20.12%, providing insight into the company's sales performance and growth. The gross profit is $271.88M. Operating income is noted at $33.28M. Furthermore, the EBITDA is $52.76M.
help
What is the market capitalization of Cellebrite DI Ltd. (CLBT)?
Cellebrite DI Ltd. (CLBT) has a market capitalization of $2.81B. The average daily trading volume is 1.89M, indicating the stock's liquidity and investor engagement.

News

2X Welcomes Lisa Cole as the Company's First CMO, Igniting AI Innovation and Accelerating Growth - GlobeNewswire
B2B MARKETING
MARKETING-AS-A-SERVICE
CHIEF MARKETING OFFICER
MARKETING TRANSFORMATION
7/11/2024

2X Welcomes Lisa Cole as the Company's First CMO, Igniting AI Innovation and Accelerating Growth - GlobeNewswire

Cellebrite Announces Availability of Industry-Leading Endpoint Inspector SaaS Solution on Amazon Web Services Marketplace
PRODUCT / SERVICES ANNOUNCEMENT
6/26/2024

Cellebrite Announces Availability of Industry-Leading Endpoint Inspector SaaS Solution on Amazon Web Services Marketplace

Cellebrite DI Ltd. (CLBT) Q1 Earnings and Revenues Surpass Estimates
5/23/2024

Cellebrite DI Ltd. (CLBT) Q1 Earnings and Revenues Surpass Estimates

Arbe Robotics Ltd. (ARBE) Reports Q1 Loss, Lags Revenue Estimates
5/22/2024

Arbe Robotics Ltd. (ARBE) Reports Q1 Loss, Lags Revenue Estimates

FUTU vs. CLBT: Which Stock Should Value Investors Buy Now?
5/21/2024

FUTU vs. CLBT: Which Stock Should Value Investors Buy Now?

Cellebrite Announces Participation in Upcoming Investor Conferences
CALENDAR OF EVENTS
5/16/2024

Cellebrite Announces Participation in Upcoming Investor Conferences

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level